NCT06687421 Implementation of Precision Medicine in High-risk Prostate Cancer
| NCT ID | NCT06687421 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Andreas Josefsson |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,500 participants |
| Start Date | 2024-06-10 |
| Primary Completion | 2054-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,500 participants in total. It began in 2024-06-10 with a primary completion date of 2054-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.
Eligibility Criteria
Inclusion Criteria: * Men investigated for suspected prostate cancer * Signed consent form Exclusion Criteria: * Difficulties understanding information about the study due to linguistic, cognitive or other reason
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06687421 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06687421 currently recruiting?
Yes, NCT06687421 is actively recruiting participants. Contact the research team at andreas.josefsson@umu.se for enrollment information.
Where is the NCT06687421 trial being conducted?
This trial is being conducted at Umeå, Sweden.
Who is sponsoring the NCT06687421 clinical trial?
NCT06687421 is sponsored by Andreas Josefsson. The trial plans to enroll 5,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.